Adjusted net income 1 was $12.2 million corresponding to an Adjusted EPS 1, basic of $0.34 for the three months ended March 31, 2025 compared to an Adjusted net income of $17.5 million corresponding ...

Tariffs and supply chain disruptions that raise costs of Artificial Intelligence infrastructure could slow down India’s ...

Investment banking firm Goldman Sachs recently forecasts that the U.S. has a 35% chance of entering a recession in the next year, a worrisome development for ASCs nationwide. Here are a few key ways ...

MUCH ink has been spilled about the economic cost of tariffs and the looming risk of a US recession or stagflation. While we ...

Lansing — University of Michigan economists predicted Friday increased tariffs on cars, parts, aluminum and steel will reduce Michigan's employment growth by 13,000 jobs over the next five years ...

The decline is tied to weaker demand and falling feedstock costs, especially polymer-grade propylene, amid broader economic uncertainty and tariffs. He notes softness in key end markets like ...

American workers, farmers, ranchers, and businesses have benefited from this trade deal by reducing or eliminating tariffs on goods, strengthening intellectual property protections, and improving ...

But with his recent announcement of global tariffs — and a virtual embargo on Chinese imports — he’s not only started a trade war but a full-frontal assault on new and expecting parents.

Toyota released a report Thursday projecting that President Trump’s sweeping tariffs, including automobile ... Toyota’s expected loss would result in a 20.8 percent decrease in operating ...

Mattel Chief Executive Ynon Kreiz said the El Segundo-based toy maker behind Barbie and Hot Wheels is considering raising the prices of U.S. toys because of the 145% tariffs the Trump ...

The automaker’s somber forecast for the fiscal year underscored how quickly fortunes had turned for many companies reckoning with President Trump’s tariffs. By River Akira Davis Reporting from ...

Looming tariffs on pharmaceuticals are creating uncertainty for health insurance companies and their clients, distressing a sector that relies heavily on accurately predicting costs.